2022
DOI: 10.1016/j.xinn.2022.100342
|View full text |Cite
|
Sign up to set email alerts
|

Single-cell technologies: From research to application

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
33
0
1

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 42 publications
(34 citation statements)
references
References 221 publications
0
33
0
1
Order By: Relevance
“…Through single‐cell dissecting and validation, 116 proteins such as fibroblast activation protein (FAP) and vimentin have been recognised as the markers of CAFs 117 . Borrowing concepts from ICIs, mAb targeting FAP (sibrotuzumab) was developed but failed to elicit treatment response in clinical trials 118 .…”
Section: Infiltration Of Effector Cellsmentioning
confidence: 99%
“…Through single‐cell dissecting and validation, 116 proteins such as fibroblast activation protein (FAP) and vimentin have been recognised as the markers of CAFs 117 . Borrowing concepts from ICIs, mAb targeting FAP (sibrotuzumab) was developed but failed to elicit treatment response in clinical trials 118 .…”
Section: Infiltration Of Effector Cellsmentioning
confidence: 99%
“…Over the past two decades there have been significant advancements in mesoscopic analysis of the mouse brain. It is currently possible to track single cell neurons in mouse brains, 1 observe whole brain developmental changes on a cellular level, 2 associate brain regions and tissues with their genetic composition, 3 and locally characterize neural connectivity. 4 Much of this scientific achievement has been made possible due to breakthroughs in high resolution imaging techniques that permit submicron, 3-D imaging of whole mouse brains.…”
Section: Introductionmentioning
confidence: 99%
“… 4 , 5 On the basis of nonlinear dynamical systems theory, the dynamic network biomarker (DNB) method, which uses a group of collectively fluctuated genes during a biological process rather than differentially expressed genes, has been developed to identify the critical states and to predict the leading molecules of the biological processes of disease progression by exploiting the dynamical features of the tipping points obtained from bulk omics data. 4 , 16 , 17 Among the omics data, those from single-cell transcriptomic analyses (single-cell RNA sequencing [scRNA-seq]) 18 , 19 , 20 provide a wealth of unprecedented information for detecting the tipping points and the related leading transcripts. However, the application of sophisticated, dynamics-based methods on single-cell data is limited because of the higher levels of transcript amplification noises and drop-outs than those of RNA sequencing (RNA-seq) performed on bulk cell populations.…”
Section: Introductionmentioning
confidence: 99%